Study on the T-Cell Immune Response in Individuals With HIV and Toxoplasmosis Using ELISPOT
Iskra Rainova
Rumen Harizanov
Yana Todorova
Mihaela Videnova
Eleonora Kaneva
Raina Borisova Enikova
Nina Dimitrova Tsvetkova
Conclusion: It is important to monitor patients with HIV, toxoplasmosis, and immunodeficiency. This can help prevent complications such as TE. A modified ELISPOT protocol may be required to determine the specific cell-mediated response in immunocompromised patients.
Bron: researchgate.net, lees meer